News & Announcements
GeneConvene will advance the safe and responsible exploration of genetic biocontrol technologies, a set of investigational public health tools with the potential to save lives.
These stories illustrate the unique and crucial role of the FNIH in building and managing cross-sector alliances, convening key stakeholders to tackle complex challenges, investing in the future of scientific leadership and sharing results of our collaborations to advance knowledge among the research community.
Dr. Omenn is the Harold T. Shapiro Distinguished University Professor of Computational Medicine & Bioinformatics, Internal Medicine, Human Genetics and Public Health and founding director of the Center for Computational Medicine & Bioinformatics at the University of Michigan at Ann Arbor.
This fund was established in response to the inquiries to support the NIH and NIAID in their efforts to rapidly end the threat from COVID-19 and to prepare the United States to defend against future pandemics.
This partnership will develop an international strategy for a coordinated research response to the COVID-19 pandemic.
The milestone signals regulatory support to move forward in the biomarker qualification process, an important first step in developing non-invasive biomarkers for patients with NASH.